Close

Adagene Announces Poster Presentations of Clinical Data for Two Novel Antibody Programs at ESMO Immuno-Oncology Congress 2021

Go back to Adagene Announces Poster Presentations of Clinical Data for Two Novel Antibody Programs at ESMO Immuno-Oncology Congress 2021
(NASDAQ: ADAG) Delayed: 2.75 --0 (-0%)
Previous Close $2.75    52 Week High
Open $2.75    52 Week Low
Day High $2.75    P/E N/A 
Day Low $2.75    EPS
Volume 50